Pradžia › Širdies priepuolis › Kalifornija
Širdies priepuolis klinikiniai tyrimai Kalifornija
5 tyrimai dėl Širdies priepuolis ieško dalyvių vietose Kalifornija.
Miestai Kalifornija
Oficialus tyrimo tekstas (anglų kalba)
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
- National Institute of Clinical Research, Bakersfield
- California Institute of Renal Research, Chula Vista
- The Medical Research Group, Inc., Fresno
- ir dar 27
Renkami dalyviai2/3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-21 · NCT05485961An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
- Cardiovascular Res Found, Beverly Hills
- National Heart Institute, Beverly Hills
- Diabetes Lipid Management Center, Huntington Beach
- ir dar 7
Renkami dalyviai3 fazė
Amžius nuo 18 iki 100 · Visoms lytims · Atnaujinta 2026-09-04 · NCT07517263OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
- National Heart Institute, Beverly Hills
- 310 Clinical Research, Inglewood
- University of California San Diego, La Jolla
- ir dar 11
Renkami dalyviai3 fazė
Amžius nuo 50 iki 105 · Visoms lytims · Atnaujinta 2026-08-21 · NCT07136012AI-Enabled Direct-from-ECG Ejection Fraction (EF) Severity Assessment Using COR ECG Wearable Monitor
- Orange County Heart Institute, Orange
- Peerbridge Health, Pasadena
Renkami dalyviaiStebimasis tyrimasLaukiami sveiki savanoriai
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-06-01 · NCT06699056Focused Orticumab Research for Treating Inflammation in Coronary Arteries
- Abcentra Investigational Site, Los Angeles
- Abcentra Investigational Site, Torrance
Renkami dalyviai2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-01-27 · NCT06927739Iš ClinicalTrials.gov, duomenys gauti 2026-10-04. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.